Analyst Ratings for Cidara Therapeutics (CDTX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/3/2021 | H.C. Wainwright » Updated 3/23/2023 |
Ed Arce | New Coverage | Buy (N/A) |
6.00 (6.50) |
1.45 (0.51) |
-64.83% | Details |
| 9/22/2021 | WBB Securities | Stephen Brozak | Upgrade | Strong Buy (Buy) |
6.25 (N/A) |
2.09 (0.51) |
-75.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
